Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Multi Hanna Kreasindo Tbk. (MHKI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Multi Hanna Kreasindo Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Multi Hanna Kreasindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multi Hanna Kreasindo Tbk. trades at Rp137 (market cap 510B, 7.95M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Multi Hanna Kreasindo Tbk. is far larger — about 3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Multi Hanna Kreasindo Tbk. is more actively traded (7.95M versus 96.7K). Which is the better fit depends on your goals.

MHKIOBAT
Market Cap
510B167.37B
Volume
7.95M96.7K
Lot
79.48K967
Turnover
1.1B23.82M
Average Price
138.19246.34
Value
1.1B23.82M
Indicative Equilibrium Price
137248
Indicative Equilibrium Volume
91141

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MHKI
View details
OBAT
View details

About Multi Hanna Kreasindo Tbk.

PT Multi Hanna Kreasindo Tbk (Company), was established on September 23, 2004 based on Deed of Notary Drajat Dramaji, S.H., No.165. The company became effective commercially on September 23, 2004. The parent entity of the Company is PT Multi Hanna Sinergitama and the ultimate beneficial owners of the Company are Mr. Shahabuddin and Mr. Alwi.

Read more on MHKI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT